http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S54106472-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D235-28
filingDate 1978-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ca7812df3e9833a2e81b1908e90902b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb87359e86f19cc90d7e53100b443ac1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2472a02a90997fc8a4bcd1bc108d54d
publicationDate 1979-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-S54106472-A
titleOfInvention Preparation of 4, 5, 6, 7-tetrahydro-benzimidazoline-2-thione
abstract PURPOSE: To obtain the title compound which is an intermediate for medicines in simple procedures in high yield, by treating a specific compound, readily prepared through addition reaction between 2-amino-cyclohexanone oxime and a thioisocyanate, with an acidic substance. n CONSTITUTION: A N-(2-hydroxyimino-cyclohexyl)-thiourea of formula I: (R is alkyl, allyl, or aralkyl group) is brought into contact with an acidic substance, e.g. hydrogen chloride, hydrogen bromide, sulfuric or benzenesulfonic acid, at 0W 150°C, preferably 10W100°C to give the objective compound of formula II. The thiourea of formula I is obtained by addition reaction of 2-amino-cyclohexanone oxime with a thiocyanate of formula IV according to the well-known method. Preferably, the amount of the acidic substance is 0.01 mole or more per mole of the compound of formula I. n COPYRIGHT: (C)1979,JPO&Japio
priorityDate 1978-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420124096
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449831254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723790
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414672094
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12404577
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21225539
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421241913
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID430991797
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236743911
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58684318
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559198
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236743909
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425013245
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236743906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID236311447
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88799493
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419557048
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88799492
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID20485906
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID88799491

Total number of triples: 42.